Capecitabine linked to rare eruptive keratoacanthoma in colorectal cancer patient
A 75‑year‑old woman on capecitabine for metastatic colorectal cancer developed eruptive keratoacanthoma, a rare skin condition that can mimic squamous cell carcinoma.
More news
- Your November 2026 horoscope: Career, money, relationships and health
- Medicine shortages put chronic patients at risk across public facilities
- Kenya’s silent epidemic found in diabetes and hypertensive patients
- Ethiopia: Violence in the North Is Pushing Health System to the Brink, WHO Chief Warns
- Nigeria: Nigerian Health Chiefs Confirm Negative Results in Ebola Cases